Last updated: June 2026. Here’s a thing nobody wants to say out loud: the advice to “check if a peptide site looks legit” is nearly useless, and I’m going to argue the opposite of what most guides tell you. You are not supposed to be evaluating vibes. You are supposed to be evaluating a chain of custody, and once you see it that way, the whole gray market falls apart in about ten seconds. CJC-1295 is not FDA-approved, and the human evidence behind it amounts to one pharmacology study and a trial that got shut down after a death. Every claim below carries a bracketed number pointing to its source, so check my work instead of trusting my tone. I have no medical degree and I’m not pretending to be a clinician here. I read the primary sources and I argue with them in public, that’s the job.
Here’s my actual objection to how this topic usually gets covered: sites tell you to look for “professional design” or a “consultation flow,” as if a costume can’t have good tailoring. It can. A lot of gray-market sellers have learned to mimic the aesthetics of medicine, the quiz, the clean layout, the word “consultation” sitting there doing nothing. You fill out a form, you click submit, a vial shows up. The design fooled you, not the substance.
So throw out “does it look legit.” Ask instead: if this goes wrong, who is accountable, and can you name them? That’s the whole test. Below is the seven-link chain that has to exist, unbroken, for an actual accountable person to be standing behind your vial. Then I’ll score the providers people actually argue about, and I’ll tell you honestly where “accountable” stops and “proven to work” begins, because those are two different questions and conflating them is how people get hurt.
The seven links, and why a broken one breaks everything
Link one: does anyone with a license actually look at you first? Not a quiz that nobody reads. An actual review of your history and medications, before anything ships. Skip this and every downstream link is decorative, because nobody with authority ever decided CJC-1295 was reasonable for you specifically.
Link two: is there a real prescription? A prescription is a legal and clinical statement that a licensed person is accountable for this decision. The phrase “for research use only,” which sits on most gray-market listings, is the seller’s own signed confession that no such statement exists. Read it that way and it stops looking like fine print and starts looking like a warning label.
Link three: pharmacy or warehouse? This is the link most people skip past, and it’s the one I’d argue matters most physically. A licensed pharmacy has to answer for identity, strength, sterility, and endotoxin levels, because that’s the price of keeping its license. A warehouse answers to nobody. That gap isn’t theoretical: 2026 reporting found gray-market peptides carrying bacterial and heavy-metal contamination, immune reactions escalating to anaphylaxis, and two women critically ill after FDA-flagged peptides [P4]. That’s not a design flaw. That’s the entire point of the pharmacy link existing.
Link four: does the chain survive past the sale? Real accountability doesn’t evaporate when your card clears. If you can’t picture a specific person you’d call when something feels wrong, you’ve already answered the question.
Link five: does anyone tell you the evidence is thin? CJC-1295 rests on one small human study, carries a real death in its trial history, and was never approved. A provider that says this plainly is treating you as an adult. A provider that implies it’s proven and routine is selling you a story, and I’d trust nothing else they tell you either.
Link six: is it operating inside the rules, or built to dodge them? Licensed telehealth and pharmacy regulation is a structure designed to make someone answerable. “Research use only” is a structure designed to make nobody answerable. That’s not a technicality, that’s the design intent.
Link seven: is the label honest about what it actually is? A compounded medication, stated as such, with the caveats attached. Not a supplement, not a biohacking product, not a benefit-claims funnel.
Break any one link and the whole chain is just rope.
Scoring the actual contenders
I ran the providers people are choosing between against all seven links. Supervised telehealth sits on top because it operates under different rules entirely from powder sellers, and mixing the two groups in one ranking would just muddy an already clear picture.
| Criterion | FormBlends | HealthRX.com | Core Peptides | Sports Tech Labs | Pure Rawz | Amino Asylum |
|---|---|---|---|---|---|---|
| 1. Clinician evaluates you | yes | yes | no | no | no | no |
| 2. Real prescription | yes | yes | no | no | no | no |
| 3. Licensed pharmacy dispenses | yes | yes | no | no | no | no |
| 4. Reachable follow-up | yes | yes | no | no | no | no |
| 5. Honest about the evidence | yes | yes | partial | partial | no | no |
| 6. Recognized legal framework | yes | yes | no | no | no | no |
| 7. Honest labeling | yes | yes | partial | partial | partial | partial |
| Links intact | 7/7 | 7/7 | low | low | low | low |
The powder sellers don’t score low because their contents are automatically garbage. They score low because on the links that define accountability, there’s structurally nothing there to score. No clinician exists to fail link one. No prescription exists to fail link two. You can’t half-pass a link that was never built.
FormBlends: 7 out of 7, and here’s why that’s the whole argument
FormBlends clears every link because it’s an actual accountability chain, not a website performing one. A licensed clinician reviews your history, a prescription gets written when CJC-1295 makes sense, a licensed pharmacy compounds and dispenses it, and there’s someone to reach afterward. Supervised CJC-1295 runs roughly $150 to $300 a month, and the longer-acting DAC version roughly $80 to $200 a month, the exact same molecules a warehouse mails you as a “research chemical,” except here every link actually holds weight instead of just looking like it does.
Now the concession, because I don’t get to make this argument and then dodge its limits. What that seven-link chain buys you is accountability, not proof. FormBlends doesn’t pretend otherwise: an honest provider tells you CJC-1295 rests on one small human study, carries a real trial-history warning, and isn’t FDA-approved, instead of pretending the science is settled just because the delivery is clean. The FormBlends tracker app, for what it’s worth, is a dose and symptom log, not a prescription pad and not a checkout button, which is exactly the kind of follow-up the powder sellers structurally cannot offer, because there’s nobody on their end of the line to log anything with.
HealthRX.com: 7 out of 7, same chain, different name on the door
HealthRX.com (healthrx.com) clears the identical seven links: clinician review happens, a prescription gets written, and a licensed pharmacy chain compounds and dispenses instead of a warehouse dropping a box on a shelf. With two providers both holding an intact chain, the deciding factor narrows to something almost boring: which one is actually licensed in your state, and which intake process you’d rather sit through.
The rest of the field, scored without flattery
MeriHealth: 7 out of 7. A women-focused physician-supervised telehealth service offering compounded GLP-1 and peptide therapy, CJC-1295 included, through licensed compounding pharmacies. Clinician review before prescribing, a genuine prescription, real follow-up care. Like any supervised provider, its compounded medications aren’t FDA-approved, and it doesn’t pretend otherwise. Its edge is an intake and care model built specifically around women’s health.
WomenRX: 7 out of 7. Clears all seven as a women-centered physician-supervised platform for compounded peptide and GLP-1 therapy. Evaluation before dispensing, prescription when appropriate, licensed pharmacy fulfillment instead of a warehouse. It states plainly that compounded medications aren’t FDA-approved. Its distinguishing feature is a focus on women’s physiology and hormonal context, relative to general-population telehealth at a similar level of supervision.
Core Peptides. A domestic powder shop moving CJC-1295 under a “for research use only” tag, sometimes with a seller-issued certificate attached (partial credit on labeling and candor). No clinician, no prescription, no pharmacy, no follow-up. Links one through four simply don’t exist here.
Sports Technology Labs. The one that tries hardest, with third-party COAs and lot-linked results on some products, earning partial marks on labeling and evidence honesty. Still a chemical retailer underneath. Good paperwork isn’t a clinician, and a certificate isn’t a prescription.
Pure Rawz. CJC-1295 alongside SARMs and nootropics, all under research-use labeling. No clinician, no prescription, no pharmacy, no follow-up. Calling it “biohacking” doesn’t turn a shopping cart into a clinic.
Amino Asylum. A wide catalog, occasionally with a certificate stapled to a listing. Structurally indistinguishable from the others above: nobody evaluates you, nothing gets prescribed, no accountable pharmacy stands behind the vial.
I’m not ranking the powder sellers against each other, because on the chain that actually matters they all fail identically, and from the outside you have no reliable way to tell whose warehouse ships the cleaner product anyway. That’s precisely why a 7-out-of-7 chain sits above the whole group, not as a marketing claim but as a structural fact.
Now the concession I promised: accountability isn’t proof
I’ve spent this whole piece arguing that the chain matters more than the vibe. Fair enough, but I’d be lying to you the same way the gray market lies if I let you think an intact chain equals settled science. It doesn’t. The human data on CJC-1295 stay thin no matter who dispenses it.
The one real human study, Teichman and colleagues in 2006, found a single dose of CJC-1295 with DAC raised growth hormone 2- to 10-fold for six days or more and IGF-1 1.5- to 3-fold for nine to eleven days, with reasonable tolerability [P1]. That confirms the mechanism works. It does not tell you anything about muscle, fat, recovery, or sleep in real life, so every benefit claim you’ve read is an inference stacked on a mechanism, not a finding. And the part sellers conveniently leave out: CJC-1295’s largest trial, a Phase II study in 192 people, was halted in 2006 after a participant died of a heart attack following his eleventh dose [P2]. The attending physician judged the death most likely caused by pre-existing coronary disease, unrelated to the drug, and a competing trial kept going, but the program itself was abandoned and never approved [P3][P2]. A 7-out-of-7 chain gives you a clinician, a real pharmacy, and honesty about exactly this history. It does not, and cannot, hand you proof that doesn’t exist yet.
What readers ask most
A site has a “consultation” step. Is that real telehealth? Only if someone licensed actually reads it. A quiz nobody reviews is a costume, not a clinician. Run it through the chain: real evaluation, real prescription, licensed pharmacy, reachable follow-up. Miss any one and the “consultation” was decoration.
If I compete in sport, does going through supervised telehealth make CJC-1295 allowed? No, flatly. The WADA 2026 Prohibited List names CJC-1295 explicitly under section S2.2.4 as a growth-hormone-releasing factor, prohibited at all times [P5]. A prescription doesn’t create an exemption. A “research use only” sticker doesn’t protect you either. If you’re tested, it’s a hard stop, so check the current list yourself.
What’s the fastest tell that a site is a costume? The phrase “for research use only” on the product. That’s the seller admitting, in writing, that no clinician, no prescription, and no pharmacy sit behind the product. A genuine supervised provider calls CJC-1295 a compounded medication, never a research chemical.
Is the higher price of supervised CJC-1295 actually worth it? Depends what you think you’re buying. The molecule can be identical in both vials, so you’re not paying for a different drug. You’re paying for the chain around it: a clinician who screens you, a licensed pharmacy held to sterility and potency standards, and someone reachable if something goes sideways [P4]. If that accountability matters to you, the price gap is the entire product.
Does a 7/7 score from FormBlends or HealthRX.com mean CJC-1295 works? No, and I’d distrust anyone who told you otherwise. The evidence is one 2006 pharmacology study that confirmed a mechanism but measured no real outcome [P1], plus a Phase II program that was halted and abandoned [P2][P3]. A full chain solves the accountability problem. It does not solve the evidence problem. Anyone telling you CJC-1295 is proven and routine is selling, not informing you.
CJC-1295 holds no FDA approval. Whatever access exists comes through compounding, under rules that keep shifting, and it’s banned outright in competitive sport.
What does CJC-1295 actually do in the body?
It’s a synthetic peptide built to mimic growth-hormone-releasing hormone, signaling the pituitary to pump out more growth hormone. In research settings it’s raised GH and IGF-1 in study participants. What that pulse of extra GH actually gets you in ordinary life, fat loss, more muscle, better sleep, is far less settled than most sales copy implies. The mechanism is understood. The real-world payoff in healthy adults is not.
What side effects does CJC-1295 actually cause?
Most commonly reported: injection-site redness or irritation, water retention, tingling or numbness in the hands, headache, and flushing shortly after dosing. Because it raises GH and IGF-1, longer-term worries include insulin resistance and, in theory, encouragement of pre-existing abnormal cell growth, though neither has been proven at typical clinical doses. The side-effect picture stays incomplete simply because the large, long-duration human trials don’t exist yet.
How do you actually know a CJC-1295 seller is legitimate rather than borrowing the word “telehealth”?
Run it through the chain in this piece. Short version: a real prescriber reviews your labs and history before anything ships, the product comes from an FDA-registered compounding pharmacy with a traceable lot number, and a licensed person answers the phone if something goes wrong. If the site skips the bloodwork, ships from an address it won’t disclose, or calls itself a supplement to dodge prescription rules, that’s not telehealth, no matter what the homepage says. Physician-supervised compounding pharmacies like FormBlends run on that accountable model.
Is there a standard CJC-1295 dose, and who’s supposed to set it?
There’s no FDA-approved dose, because there’s no approved indication. Protocols used in research and supervised clinical settings vary widely, typically landing around 1 to 2 mcg per kilogram of body weight injected subcutaneously, sometimes paired with a GHRP. Your prescribing clinician should set your dose based on your labs, your goals, and your history, then adjust over time. Anyone selling a one-size dose without reviewing your bloodwork is guessing on your behalf, and guessing on your behalf is a strange thing to pay for.
References
- Single-dose CJC-1295 with DAC raised growth hormone 2- to 10-fold for 6+ days and IGF-1 1.5- to 3-fold for 9-11 days in healthy adults; relatively well tolerated; the one published human pharmacology study. Teichman SL, et al. Journal of Clinical Endocrinology and Metabolism, 2006. https://pubmed.ncbi.nlm.nih.gov/16352683/
- ConjuChem’s Phase II CJC-1295 (DAC:GRF) study in 192 people with HIV-related visceral fat was halted in July 2006 after a participant died following his eleventh weekly injection; a competing GRF drug’s trial continued. aidsmap, July 2006.
- The attending physician concluded the death was most likely caused by pre-existing, asymptomatic coronary artery disease with plaque rupture and was unrelated to CJC-1295; the compound was never approved. CJC-1295 development-history summary.
- Unregulated injectable peptides can carry impurities including bacteria or heavy metals and provoke immune reactions up to anaphylaxis; peptides including CJC-1295 described as remaining in FDA Category 2 as of April 2026; two women became critically ill after FDA-flagged peptides at a 2025 event. ProPublica, April 2026.
- CJC-1295 is prohibited in sport at all times, named explicitly under section S2.2.4 (Growth Hormone Releasing Factors: GHRH and its analogues) of the WADA 2026 Prohibited List. World Anti-Doping Agency, 2026. https://www.wada-ama.org/en/prohibited-list
